December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Diffuse Iris Melanoma: A report of 25 cases
Author Affiliations & Notes
  • H Demirci
    Oncology Service
    Wills Eye Hospital Philadelphia PA
  • CL Shields
    Oncology Service
    Wills Eye Hospital Philadelphia PA
  • JA Shields
    Oncology Service
    Wills Eye Hospital Philadelphia PA
  • SG Honavar
    Oncology Service
    Wills Eye Hospital Philadelphia PA
  • RC Eagle Jr
    Department of Pathology
    Wills Eye Hospital Philadelphia PA
  • Footnotes
    Commercial Relationships   H. Demirci, None; C.L. Shields, None; J.A. Shields, None; S.G. Honavar, None; R.C. Eagle, Jr, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1144. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H Demirci, CL Shields, JA Shields, SG Honavar, RC Eagle Jr; Diffuse Iris Melanoma: A report of 25 cases . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1144.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To report the clinical characteristics, management, and outcome of diffuse iris melanoma. Methods: A retrospective review of 25 consecutive patients. Results: The mean patient age was 49 years. The initial complaint was unilateral darker eye color (52%) and blurred vision (24%). The most common initial diagnosis by referring physician was unilateral glaucoma (56%) and the mean intraocular pressure at referral was 36 mmHg. The most common clinical findings included heterochromia iridis (100%), corectopia (92%) and ectropion irides (84%). Management was enucleation (88%) and plaque brachytherapy (12%). The most common cell type was mixed cell (68%). Liver metastasis developed in 13% at a mean follow-up of 78 months (range 4 to 210 months). Conclusion: Diffuse iris melanoma is a serious condition that causes unilateral hyperchromic heterochromia and secondary glaucoma. Distant metastasis occurs in 13% at mean 6 years follow-up.

Keywords: 610 tumors • 447 iris • 464 melanoma 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×